Fred Alger Management, LLC Galapagos Nv Transaction History

Fred Alger Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $1.3 Million - $1.88 Million	-10,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $557,250 - $644,650	5,000 Added 100.0%	10,000 $1.29 Million
Q1 2019 May 14, 2019	BUY	$89.61 - $117.78 $448,050 - $588,900	5,000 New	5,000 $589,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.